Atlas Trials

Efficacy and Safety of TD-1473 in Crohn's Disease

Clinical trial NCT03635112 · TERMINATED

Trial details

NCT number
NCT03635112
Sponsor
Theravance Biopharma
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2018-11-19
Primary completion
2021-12-30
Enrollment
167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.